| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |